India drug regulator asks Dr Reddy's for more data on Sputnik V vaccine

An expert panel of India's drug regulator on Friday sought additional data from drugmaker Dr.Reddy's Laboratories on its Sputnik V COVID-19 vaccine trial, in its second such request after an initial evaluation in February.

  The committee asked the company to submit a comparative analysis of late-stage immunogenicity data from both its Indian studies and an ongoing Russian study, as well as data on serious adverse events and positive cases reported till date. ALSO READ: Number of Covid-19.....

This article is no longer available in our repository.

There could be multiple reasons for this.